AROSIO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 3.318
EU - Europa 2.006
AS - Asia 951
SA - Sud America 54
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.339
Nazione #
US - Stati Uniti d'America 3.240
IT - Italia 439
SG - Singapore 363
CN - Cina 325
DE - Germania 294
RU - Federazione Russa 277
SE - Svezia 217
IE - Irlanda 182
UA - Ucraina 127
GB - Regno Unito 114
AT - Austria 81
HK - Hong Kong 75
CA - Canada 71
PL - Polonia 69
FR - Francia 53
FI - Finlandia 51
IN - India 50
BR - Brasile 45
BE - Belgio 30
DK - Danimarca 30
TR - Turchia 30
VN - Vietnam 30
JP - Giappone 18
NL - Olanda 18
ID - Indonesia 15
IR - Iran 14
KR - Corea 12
MX - Messico 6
CH - Svizzera 4
TW - Taiwan 4
CL - Cile 3
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
ES - Italia 2
EU - Europa 2
IL - Israele 2
LT - Lituania 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
LV - Lettonia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 6.339
Città #
Ann Arbor 791
Houston 299
Chandler 266
Woodbridge 254
Singapore 222
Dublin 173
Frankfurt am Main 165
Jacksonville 161
Milan 160
Dearborn 155
Wilmington 153
Ashburn 139
Fairfield 133
Santa Clara 96
New York 88
Vienna 81
Princeton 72
Hong Kong 70
Kraków 65
Nanjing 58
Shanghai 54
Seattle 50
Cambridge 45
Lachine 32
Pisa 32
Brussels 30
Lecco 24
Shenyang 24
Beijing 23
Dong Ket 21
Fremont 20
Boardman 19
Guangzhou 18
Ottawa 17
Moscow 15
Nanchang 15
Tianjin 15
Jakarta 14
Pune 14
Changsha 13
Jinan 13
Andover 12
Hebei 12
Lawrence 12
Munich 12
Los Angeles 11
Zhengzhou 11
Council Bluffs 10
Falls Church 10
Helsinki 10
Altamura 9
Edmonton 9
Lappeenranta 9
San Diego 9
London 8
Jiaxing 7
Nuremberg 7
Torino 7
Cagliari 6
Düsseldorf 6
Toronto 6
Belo Horizonte 5
Brusuglio 5
Kunming 5
Norwalk 5
Rome 5
Varedo 5
Dallas 4
Kumamoto 4
Lanzhou 4
Mountain View 4
Ningbo 4
Odessa 4
Taipei 4
Almaty 3
Amsterdam 3
Bari 3
Brendola 3
Cantù 3
Catanzaro 3
Cluj-Napoca 3
Detroit 3
Falkenstein 3
Hangzhou 3
Hefei 3
Luzhou 3
Melegnano 3
Namyangju 3
Portsmouth 3
Redmond 3
Ripalta Cremasca 3
Saint Petersburg 3
Santa Rosa 3
Seocho-gu 3
Siena 3
São Paulo 3
Tehran 3
Tokyo 3
Varese 3
Zanjan 3
Totale 4.428
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 341
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 333
null 296
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 259
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 233
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 222
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 220
Micrornas in als: from molecular mechanisms to clinical relevance 213
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 212
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 200
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 197
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 189
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 186
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 184
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 184
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 183
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 181
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 171
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 166
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 157
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 157
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 155
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 151
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 150
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 146
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 146
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 145
Study of transcriptional alterations in Amyotrophic Lateral Sclerosis 145
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 144
the MonzALS collaborative network 140
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 136
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 134
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 131
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 121
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 116
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 115
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 19
Totale 6.578
Categoria #
all - tutte 20.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 0 0 0 0 64 74 22
2020/2021817 28 58 103 111 81 45 79 57 69 77 48 61
2021/2022413 29 65 45 27 31 30 14 39 25 18 35 55
2022/2023894 71 250 76 114 68 138 7 56 69 6 18 21
2023/2024614 29 26 16 23 77 188 100 27 20 17 11 80
2024/20251.138 75 172 131 47 123 57 52 68 181 232 0 0
Totale 6.578